Kyverna Therapeutics Stock Forecast

Sell candidate since Jul 10, 2026 Loss -12.20%

The Kyverna Therapeutics, Inc. stock price gained 0.134% on the last trading day (Friday, 17th Jul 2026), rising from $7.44 to $7.45. During the last trading day the stock fluctuated 6.67% from a day low at $7.20 to a day high of $7.68. The price has been going up and down for this period, and there has been a -16.2% loss for the last 2 weeks. Volume fell on the last day by -860 thousand shares and in total, 873 thousand shares were bought and sold for approximately $6.50 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -12.86% during the next 3 months and, with a 90% probability hold a price between $5.93 and $8.49 at the end of this 3-month period.

KYTX Signals & Forecast

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Kyverna Therapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.10 and $8.29. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, July 08, 2026, and so far it has fallen -24.82%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Kyverna Therapeutics, Inc. stock

Kyverna Therapeutics, Inc. finds support from accumulated volume at $7.44 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.480 between high and low, or 6.67%. For the last week, the stock has had daily average volatility of 6.55%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (KYTX) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Kyverna Therapeutics, Inc. to open at $7.44, and during the day (based on 14 day Average True Range), to move between $7.15 and $7.75, which gives a possible trading interval of +/-$0.606 (+/-8.48%) up or down from last closing price. If Kyverna Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 8.48% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $7.44 (0.13%) than the resistance at $8.44 (13.29%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Kyverna Therapeutics, Inc. stock A Buy?

Kyverna Therapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.149 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $7.44 ( 0.0895%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk